These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9061357)
1. Recognition of cytoplasmic yeast antigens of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii by immune human sera. Hamilton AJ; Figueroa JI; Jeavons L; Seaton RA FEMS Immunol Med Microbiol; 1997 Feb; 17(2):111-9. PubMed ID: 9061357 [TBL] [Abstract][Full Text] [Related]
2. Murine monoclonal antibodies recognizing a non-capsular antigen that distinguishes between Cryptococcus neoformans var. neoformans and C. neoformans var. gattii. Hamilton AJ; Bartholomew MA; Figueroa J; Fenelon LE; Hay RJ Trans R Soc Trop Med Hyg; 1991; 85(1):123-7. PubMed ID: 2068741 [TBL] [Abstract][Full Text] [Related]
3. A 34- to 38-kilodalton Cryptococcus neoformans glycoprotein produced as an exoantigen bearing a glycosylated species-specific epitope. Hamilton AJ; Jeavons L; Hobby P; Hay RJ Infect Immun; 1992 Jan; 60(1):143-9. PubMed ID: 1370270 [TBL] [Abstract][Full Text] [Related]
4. Biochemical comparison of the Cu,Zn superoxide dismutases of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii. Hamilton AJ; Holdom MD Infect Immun; 1997 Feb; 65(2):488-94. PubMed ID: 9009302 [TBL] [Abstract][Full Text] [Related]
5. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Dong ZM; Murphy JW Infect Immun; 1995 Jul; 63(7):2632-44. PubMed ID: 7790079 [TBL] [Abstract][Full Text] [Related]
6. Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice. Capilla J; Maffei CM; Clemons KV; Sobel RA; Stevens DA Med Mycol; 2006 Nov; 44(7):601-10. PubMed ID: 17071553 [TBL] [Abstract][Full Text] [Related]
7. Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil. Rozenbaum R; Gonçalves AJ; Wanke B; Caiuby MJ; Clemente H; Lazera Mdos S; Monteiro PC; Londero AT Mycopathologia; 1992 Sep; 119(3):133-6. PubMed ID: 1435954 [TBL] [Abstract][Full Text] [Related]
8. Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting. Lamura L; Matthews RC; Barchiesi F; Donahoe M; Burnie JP; Scalise G J Infect; 2000 Jan; 40(1):64-8. PubMed ID: 10762114 [TBL] [Abstract][Full Text] [Related]
9. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. Dromer F; Gueho E; Ronin O; Dupont B J Clin Microbiol; 1993 Feb; 31(2):359-63. PubMed ID: 8432823 [TBL] [Abstract][Full Text] [Related]
10. Production of species-specific murine monoclonal antibodies against Cryptococcus neoformans which recognize a noncapsular exoantigen. Hamilton AJ; Bartholomew MA; Figueroa J; Fenelon LE; Hay RJ J Clin Microbiol; 1991 May; 29(5):980-4. PubMed ID: 2056065 [TBL] [Abstract][Full Text] [Related]
11. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts. Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631 [TBL] [Abstract][Full Text] [Related]
12. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire]. Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313 [TBL] [Abstract][Full Text] [Related]
13. [Cryptococcus neoformans chemotyping. Review of the literature. New epidemiologic data on cryptococcosis. Our experience with the use of C.G.B. media in the study of this yeast]. de Melo NT; Lacaz Cda S; Charbel CE; Pereira AD; Heins-Vaccari EM; França-Netto AS; Machado Ldos R; Livramento JA Rev Inst Med Trop Sao Paulo; 1993; 35(5):469-78. PubMed ID: 8115818 [TBL] [Abstract][Full Text] [Related]
14. Cryptococcus neoformans var. gattii in India. Padhye AA; Chakrabarti A; Chander J; Kaufman L J Med Vet Mycol; 1993; 31(2):165-8. PubMed ID: 8509953 [TBL] [Abstract][Full Text] [Related]
15. Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line. Olave MC; Vargas-Zambrano JC; Celis AM; Castañeda E; González JM Mycoses; 2017 Jul; 60(7):447-453. PubMed ID: 28338245 [TBL] [Abstract][Full Text] [Related]
16. Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects. Speed BR; Kaldor J; Cairns B; Pegorer M J Med Vet Mycol; 1996; 34(3):187-93. PubMed ID: 8803799 [TBL] [Abstract][Full Text] [Related]
17. Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans. Kwon-Chung KJ; Wickes BL; Booth JL; Vishniac HS; Bennett JE Infect Immun; 1987 Aug; 55(8):1751-4. PubMed ID: 3112009 [TBL] [Abstract][Full Text] [Related]
18. Cryptococcus neoformans- and Cryptococcus gattii-specific IgG, IgA and IgM differ among children and adults with and without cryptococcosis from Colombia. Becerra-Álvarez P; Escandón P; Lizarazo J; Quirós-Gómez Ó; Firacative C Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36066645 [TBL] [Abstract][Full Text] [Related]
19. Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable. De Jesus M; Chow SK; Cordero RJ; Frases S; Casadevall A Eukaryot Cell; 2010 Jul; 9(7):1018-28. PubMed ID: 20061411 [TBL] [Abstract][Full Text] [Related]